MDXG Q1 2018 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$84M+15.9% YoY

Gross Profit

$75M88.9% margin

Operating Income

$3M3.5% margin

Net Income

$5M5.5% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$7M

Stock-Based Comp.

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$73M	+15.9%
Gross Profit	$75M	$64M	+17.1%
Operating Income	$3M	$6M	-52.0%
Net Income	$5M	$4M	+6.7%